Equities research analysts expect that ICON Public Limited (NASDAQ:ICLR) will post earnings per share of $1.83 for the current quarter, Zacks Investment Research reports. Seven analysts have issued estimates for ICON Public’s earnings, with estimates ranging from $1.78 to $1.87. ICON Public also posted earnings of $1.83 per share during the same quarter last year. The company is expected to report its next quarterly earnings results on Wednesday, February 24th.
According to Zacks, analysts expect that ICON Public will report full-year earnings of $6.46 per share for the current year, with EPS estimates ranging from $6.42 to $6.50. For the next financial year, analysts anticipate that the company will report earnings of $7.87 per share, with EPS estimates ranging from $7.17 to $8.16. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research analysts that cover ICON Public.
Separately, Zacks Investment Research upgraded shares of ICON Public from a “sell” rating to a “hold” rating in a research note on Wednesday, January 13th. Eight analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $185.00.
A number of large investors have recently bought and sold shares of ICLR. Todd Asset Management LLC lifted its position in shares of ICON Public by 18.6% during the 4th quarter. Todd Asset Management LLC now owns 103,487 shares of the medical research company’s stock worth $20,177,000 after purchasing an additional 16,225 shares during the last quarter. Kornitzer Capital Management Inc. KS grew its position in ICON Public by 1.7% in the 4th quarter. Kornitzer Capital Management Inc. KS now owns 84,766 shares of the medical research company’s stock worth $16,528,000 after purchasing an additional 1,400 shares during the last quarter. Pinnacle Associates Ltd. acquired a new stake in ICON Public during the third quarter worth about $215,000. CWM LLC boosted its position in shares of ICON Public by 40.4% during the 3rd quarter. CWM LLC now owns 198 shares of the medical research company’s stock valued at $38,000 after acquiring an additional 57 shares in the last quarter. Finally, Avantax Advisory Services Inc. boosted its stake in shares of ICON Public by 26.7% in the 3rd quarter. Avantax Advisory Services Inc. now owns 1,759 shares of the medical research company’s stock valued at $335,000 after purchasing an additional 371 shares in the last quarter. Institutional investors and hedge funds own 81.70% of the company’s stock.
ICON Public Company Profile
ICON Public Limited Company, a clinical research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. It specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
Recommended Story: Fiduciary
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ICON Public Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICON Public and related companies with MarketBeat.com's FREE daily email newsletter.